SELLAS Life Sciences (SLS) Long-Term Deferred Tax (2011 - 2016)

SELLAS Life Sciences (SLS) has 6 years of Long-Term Deferred Tax data on file, last reported at -$5.7 million in Q4 2016.

• On a quarterly basis, Long-Term Deferred Tax fell 4.49% year-over-year to -$5.7 million in Q4 2016; TTM through Dec 2016 was -$5.7 million, a 4.49% decrease from a year earlier, with the FY2016 full-year figure at -$5.7 million, down 4.49% from the prior year.
• Long-Term Deferred Tax for Q4 2016 stood at -$5.7 million, down from -$5.4 million in the prior quarter.
• Over the last five years, Long-Term Deferred Tax for SLS reached as high as -$5.1 million in Q1 2012 and fell as low as -$5.7 million in Q4 2016.
• Historically, Long-Term Deferred Tax has averaged -$5.1 million across 5 years, with a median of -$5.1 million in 2012.
• Across the five-year window, Long-Term Deferred Tax changed 0.0% in 2012 and decreased 7.22% in 2015, its largest moves.
• Year by year, Long-Term Deferred Tax stood at -$5.1 million in 2012, then changed by 0.0% to -$5.1 million in 2013, then changed by 0.0% to -$5.1 million in 2014, then slipped by 7.22% to -$5.4 million in 2015, then fell by 4.49% to -$5.7 million in 2016.
• Per Business Quant data, the three most recent Long-Term Deferred Tax figures were -$5.7 million in Q4 2016, -$5.4 million in Q4 2015, and -$5.1 million in Q3 2015.